INTRODUCTION
============

Genome stability maintenance is a complex process involving the coordination of essentially all DNA transactions, including transcription, chromatin state, DNA replication, DNA repair, and mitosis. Regulation of genome stability is critical to prevent cancer ([@B23]). While screens across model organisms and human cells have implicated numerous genes as regulators of genome maintenance, in many cases we do not understand the mechanism of action ([@B34]; [@B39]).

Defects in RNA processing have been implicated in genome instability across species and in both human cancer and repeat-expansion diseases ([@B35]). Indeed, RNA splicing factors are frequently mutated in cancers where they shift gene expression landscapes, favoring oncogenesis ([@B15]; [@B18]; [@B26]). Previous work has suggested that loss of splicing factors like pre-mRNA-splicing factor 2/alternative splicing factor (SF2/ASF) ([@B28]), or treatment with splicing inhibitors ([@B48]), causes the accumulation of DNA:RNA hybrids in genomic DNA. These three-stranded R-loop structures contribute to genome instability by exposing single-stranded DNA (ssDNA) and by blocking replication forks, causing replication stress induced genome instability ([@B1]; [@B10]). Indeed, splicing has been ascribed a protective role in genome maintenance in yeast ([@B6]). More recently, cancer-associated mutations in splicing factors such as SRSF2 and U2AF1 have been attributed roles in R-loop prevention related to genome instability in myelodysplastic syndromes ([@B12]). These data compound other observations indicating that transcription termination ([@B38]), 3′-end processing ([@B40]), and mRNA packaging and export mutants ([@B22]) together create a robust R-loop prevention system.

Other data have suggested that splicing factor disruption, such as loss of CDK12, causes changes in gene expression, which reduce the activity of canonical genome maintenance factors ([@B5]). Indeed, cancer-associated mutations in splicing factor SF3B1 have been shown to disrupt splicing of DNA damage response--­related transcripts in myelodysplastic syndromes ([@B18]). There is little evidence for gene expression changes driving genome instability in yeast splicing mutants, but cell-cycle delays, possibly linked to genome instability, have been previously connected to defective tubulin mRNA splicing in some mutants ([@B7]). Whether altered gene expression, R-loops, or both contribute to genome instability in splicing mutants is unclear.

We previously identified many spliceosome components whose disruption in yeast leads to genome instability ([@B39]). Subsequent work found that only a handful of these genome destabilizing splicing mutants caused detectable increases in bulk R-loop levels ([@B9]). Importantly, only 5% of yeast genes encode introns reducing the complexity of interpreting specific splicing changes as drivers of genome instability ([@B33]). Here we set out to test the contribution of R-loops versus gene expression changes in splicing-loss induced genome instability in yeast. While we observe evidence of R-loop induced DNA damage in a mutant allele of *SNU114*, all splicing mutants appear to cause aberrant splicing of the α-tubulin transcript from the *TUB1* gene. A mitotic defect arising from Tub1 depletion is therefore a common driver of chromosome loss in yeast splicing mutants.

RESULTS AND DISCUSSION
======================

Splicing factor mutations lead to chromosome instability
--------------------------------------------------------

Previous screens have identified at least 25 splicing proteins that, when disrupted in yeast, lead to chromosomal instability (CIN) ([@B39]). To begin to understand whether R-loops or other mechanisms drove genome instability, we conducted CIN assays in strains with mutations in each of the core snRNP complexes involved in establishing the splicing reaction ([@B31]). We originally tested point mutations in *HSH155* that were orthologous to those found in SF3B1 in human cancers; however, these alleles exhibited weak or no splicing defects and stable genomes, consistent with only minor effects seen in other studies (unpublished data) ([@B42]; [@B8]). Since each spliceosomal snRNP is essential, we instead used temperature-sensitive (ts) alleles of *YHC1* (U1), *HSH155* (U2), and *SNU114* (U4/U6.U5), each of which had strong splicing defects as measured with a LacZ splicing reporter or at endogenously spliced gene *RPL33B* (Supplemental Figure S1, A and B). In all three mutants, we observed increases in artificial chromosome loss by the chromosome transmission fidelity (ctf) assay, which measures loss of an artificial chromosome fragment, confirming our previous findings ([@B39]) ([Figure 1A](#F1){ref-type="fig"}). We next measured the stability of a centromere (CEN) plasmid and found that splicing-­defective cells have increased plasmid loss relative to wild type (WT) ([Figure 1B](#F1){ref-type="fig"}). Since these two assays rely on the loss of episomes, we tested the stability of endogenous chromosomes by monitoring a strain with an integrated LacO array on ChrIII in cells expressing LacI-GFP to create a green fluorescent spot marking the chromosome. In haploid unbudded G1 cells, only a single GFP spot should be present; however, we observed that all splicing mutants tested showed an increased rate of gain of a LacI-GFP marked chromosome III, suggesting that a chromosome gain event has taken place ([Figure 1C](#F1){ref-type="fig"}). Thus, multiple assays indicate splicing mutants led to a significant increase in chromosomal instability.

![Genome instability phenotypes of splicing mutants. (A) CTF phenotypes indicated by the percentage of sectored colonies. Right, representative images. (B) Plasmid loss frequency. \*\*\**p* = 0.0005; \*\*\*\**p* \< 0.0001 (C) Frequency of unbudded cells with \>1 GFP-marked LacO array. Left, representative images. Dashed lines indicate cell outlines; scale bar = 2 μm. Fisher's exact test was used to calculate statistical significance. For all figures where applicable mean values with SEM bars are shown, *n = 3*.](mbc-30-191-g001){#F1}

R-loop accumulation and associated DNA damage in snu114-60
----------------------------------------------------------

The CIN phenotypes observed in splicing mutants could arise by several mechanisms, including the formation of transcription coupled R-loops ([@B28]; [@B6]). To test this model, we first performed chromosome spreads and used the S9.6 antibody to detect DNA:RNA hybrid levels in these spreads with immunofluorescence ([@B47]). As reported previously, *yhc1-1* and *snu114-60* alleles showed higher levels of R-loop accumulation compared with WT, while the *hsh155-1* allele had no increase in R-loops ([Figure 2A](#F2){ref-type="fig"}) ([@B9]). We elected to pursue comparison of *snu114-60* and *hsh155-1* since both alleles disrupt splicing and exhibit strong CIN phenotypes but have opposing effects on R-loop levels. In addition *yhc1-1* cells are very sick across temperatures, making some assays technically unreliable. Consistent with the lack of R-loop accumulation in *hsh155-1*, when we analyzed Rad52-GFP foci, a marker of DNA damage repair that should increase if R-loops are driving genome instability, we found that only *snu114-60* increased Rad52 foci frequency ([Figure 2B](#F2){ref-type="fig"}). Importantly, this DNA damage phenotype could be partially suppressed by ectopic expression of RNaseH1 (*RNH1*), similarly to a *rnh1*Δ*rnh201*Δ control strain ([Figure 2C](#F2){ref-type="fig"}). To further test phenotypes known to correlate with aberrant R-loop levels, we used a plasmid-based direct repeat recombination system to test for hyperrecombination and again only *snu114-60* showed a significant increase in recombination compared with WT ([Figure 2D](#F2){ref-type="fig"}, *mft1*Δ is a hyperrecombination positive control \[[@B11]\]). We also tested the impact of *snu114-60* on recombination at an integrated recombination substrate flanking a replication origin to assess the potential for replication-transcription conflicts that give rise to DNA damage and promote recombination. *snu114-60* also causes hyperrecombination in this chromosomal context in a manner that was suppressed by *RNH1* ([Figure 2E](#F2){ref-type="fig"}). These data show that, while splicing alleles like *snu114-60* contribute to R-loop accumulation and associated DNA damage, R-loops are not a unifying mechanism of genome instability across the various spliceosomal snRNP mutants ([@B9]).

![R-loop-associated genome instability in *snu114-60*. (A) s9.6 antibody staining intensities in chromosome spreads. \*\*\*\**p* \< 0.0001 relative to WT -RNH1. Right, representative images; scale bar = 2 μm. (B) Frequency of Rad52-GFP foci (highlighted with gray arrows), scale bar = 5 μm. (C) Suppression of Rad52-GFP foci by ectopic *RNH1* expression. (D, E) Frequency of direct repeat recombination on the indicated plasmid (D) or integrated genomic reporter (E). Reporter construct schematics are presented above each panel. (F) Representative Western blot of Yra1 protein level in the indicated strains and temperatures. (A, C, E) one-way ANOVA, (B) Fisher's exact test, and (D) Student's *t* test. \*\**p* \< 0.01; \*\*\*\**p* \< 0.0001.](mbc-30-191-g002){#F2}

It was puzzling that *snu114-60* led to increased recombination in reporters that do not contain introns and thus presumably do not recruit the spliceosome in either WT or *snu114-60* cells. This raised the possibility that the expression of an R-loop regulator was sensitive to disruption of Snu114 activity and that the *snu114-60* mutation selectively depleted this factor. One candidate gene for this phenotype is *YRA1* which encodes an RNA export protein whose function has been linked to transcription-associated recombination and R-loop formation ([@B25]; [@B21]; [@B20]). Measuring mRNA expression levels and splicing of *YRA1* by quantitative reverse transcription PCR (RT-qPCR) indicated that *YRA1* is overexpressed in both *hsh155-1* and *snu114-60* relative to WT control and that both alleles cause intron retention of *YRA1* transcript (Supplemental Figure S1C). Both splicing mutants lead to lower levels of Yra1 protein by Western blot relative to WT control ([Figure 2F](#F2){ref-type="fig"}), consistent with previous work showing *YRA1* intron downregulating Yra1 expression in a splicing-dependent manner ([@B36]). While Yra1 loss could have caused R-loop accumulation, the similar amount of Yra1 depletion in *hsh155-1* and *snu114-60* suggests this is not the case. mRNA export is known to regulate R-loop-associated genome instability ([@B29]) and it is notable that several RNA export proteins are encoded by transcripts with complex splicing behavior. For example, *DBP2,* which encodes an RNA helicase and binding partner of Yra1, has the largest intron and its levels are also autoregulated by its intron ([@B4]). Mtr2, another mRNA transport regulatory protein, is encoded by one of only a few *Saccharomyces cerevisiae* genes to exhibit alternative splice isoforms ([@B16]). Thus, while Yra1 protein levels alone are insufficient to explain R-loop--driven instability in *snu114-60*, it is possible that these other factors play a role. This awaits a more systematic study of proteome changes among R-loop regulators in splicing mutants.

Genetic interaction profiling reveals mitotic defects in hsh155-1
-----------------------------------------------------------------

Knowing that R-loops likely do not account for genome instability in some splicing mutants ([@B9]), we sought to understand common mechanisms. Mutations in *HSH155* exhibited strong CIN phenotypes but showed no evidence of increased DNA damage or R-loops ([Figure 2](#F2){ref-type="fig"}). We hypothesized that if a common mechanism of CIN existed for splicing mutants, it would be at play in *hsh155-1* alleles. To determine this function, we performed a synthetic genetic array (SGA) screen using *hsh155-1* as a query strain. This screen identified 102 negative and 103 positive genetic interaction candidates (Supplemental Table S1). A greater-than-expected number of essential intron-containing genes were negative interactors, consistent with a splicing defect enhancing phenotypes of these mutants (Supplemental Table S1). Positive interactions with proteasome subunits or translational apparatus could reflect stabilization of mutant Hsh155 protein leading to healthier cells (Supplemental Table S1) ([@B45]).

Analysis of gene ontology (GO) terms among negative genetic interactions highlighted expected groups such as *spliceosomal complex assembly* (13.6-fold enriched) and *mRNA processing* (5.5 fold) (Supplemental Table S2). Other potentially surprising GO terms such as *retrograde vesicle-mediated transport, Golgi to ER* (11.6 fold), and *Golgi-associated vesicle* (7.4 fold) (Supplemental Table S2) can be explained by the preponderance of intron-containing genes in this pathway (e.g., *SNC1*, *BET1*, *SEC27*, *SFT1*, *SAR1*, and *YIP3* all encode introns that could cause a vesicle trafficking defect in splicing mutants). Dramatic enrichment for cytoskeletal processes among negative genetic interaction partners of *hsh155-1* was also seen (Supplemental Tables S1 and S2) and was expected based on the enrichment of intron-containing genes in this pathway (e.g., *ACT1*, *TUB1*, *MCM21*, *COF1*, *GIM5*, *CIN2*, *TUB3*, and *DYN2* encode introns) ([@B33]). The clearest direct connection to chromosome segregation also came from this analysis of GO terms in this group. Terms like *attachment of spindle microtubules to kinetochore* were highly enriched (19.5 fold) (Supplemental Table S2). GO term enrichments visualized with REVIGO ([@B41]) highlight this with processes like *microtubule polymerization* and *mitotic sister chromatid biorientation* and components like the *Mis12/MIND type complex* of the kinetochore ([Figure 3, A and B](#F3){ref-type="fig"}).

![Genetic interaction network of *hsh155-1*. (A) GO biological process and (B) cellular component enrichments for *hsh155-1* negative interactions (Supplemental Tables S1 and S2). Warmer colors associate with higher enrichment. (C, D) Validation of negative genetic interactions by (C) spot dilution assays and (D) growth curves. For D, light gray bars: fitness of single mutants; dashed lines: calculated expected fitness of double mutants using multiplicative model; dark gray bars: observed fitness of double mutants. Two-way ANOVA was used to calculate statistical significance between observed and expected fitness of double mutants. \**p* \< 0.05; \*\**p* \< 0.01; \*\*\*\**p* \< 0.0001.](mbc-30-191-g003){#F3}

We validated by spot dilutions that *hsh155-1* has negative interactions with mitotic genes like cohesin (*MCD1*), core kinetochore subunits (*MIF2*), and spindle regulators (*STU1*) ([Figure 3C](#F3){ref-type="fig"}). We further used growth curves to identify subtle changes in growth in the *hsh155-1* double mutants ([Figure 3D](#F3){ref-type="fig"}). Analysis of published SGA profiles for *snu114-60* and other splicing factors ([www.thecellmap.org](http://www.thecellmap.org)) also revealed genetic dependence on a functional mitotic apparatus ([@B13]), which encouraged us to explore mitotic defects further.

SNU114 and HSH155 mutants have mitotic defects
----------------------------------------------

To test potential mitotic defects, we first measured the cell-cycle distribution of cells by budding index. After a shift to a nonpermissive temperature of 37°C, a small but significant proportion of the splicing mutant cells accumulated as large-budded G2/M cells, indicating a potential mitotic delay and defect ([Figure 4A](#F4){ref-type="fig"}). To confirm these observations, we used α-factor to arrest cells in G1 and collected samples at 30, 90, and 150 min after release for measurement of DNA content. The results confirm a clear but subtle increase in 2N cells at 150 min postrelease (Supplemental Figure S1D), compared with the positive control *ask1-2* that completely arrests in mitosis. This is consistent with the budding index data where the proportion of G2/M cells in mutants compared with wild type is only slightly elevated. To further confirm that cell-cycle progress is abnormal, we used Western blot analysis to measure levels of Clb2, a B-type cyclin that accumulates during G2 and M phases of the cell cycle ([@B3]). At the restrictive temperature, there is an increase of Clb2 protein levels in the splicing mutants, indicating that more cells are indeed in G2/M phases of the cell cycle ([Figure 4B](#F4){ref-type="fig"}). These results complement the observed negative genetic interactions between *hsh155-1* and genes with functions in spindle and kinetochore subunits ([Figure 3](#F3){ref-type="fig"}). On the basis of the literature for other splicing alleles ([@B7]), we hypothesized that cell-cycle defects in *hsh155-1* and *snu114-60* were due to spindle defects activating the spindle assembly checkpoint (SAC). To test this, we deleted the SAC regulator *MAD1* in each splicing mutant. Loss of *MAD1* further sensitized *hsh155-1* and *snu114-60* alleles to the microtubule depolymerizing drug benomyl at semipermissive temperatures ([Figure 4C](#F4){ref-type="fig"}). By quantifying the rate of endogenous chromosome III loss using the A-like faker (ALF) assay ([@B32]) in the single and double mutants at permissive temperature of 25°C, we found a dramatic synergy between disruption of *SNU114* or *HSH155* and loss of the SAC through *MAD1* deletion ([Figure 4D](#F4){ref-type="fig"}). The ALF assay measures the stability of the *MAT* locus on chromosome III and loss of this locus leads to quantifiable aberrant mating events (see *Materials and Methods*). Overall, these data are consistent with a mitotic defect in splicing mutants that requires the activity of the SAC for genome maintenance.

![Mitotic defects in spliceosome mutants. (A) Proportion of G2/M cells determined by budding relative to nuclear state determined by Hta2-mCherry fluorescence (left panels, scale bar = 2 μm); Fisher's exact test. (B) Western blot of Clb2 protein levels in the indicated strains and temperatures. (C) Spot dilution assay of benomyl sensitivity (15 μg/ml benomyl). (D) Frequency of *MAT* loss in single (black bars) and *mad1Δ* double mutants (gray bars), grown at 25°C. Right, representative images of WT, *mad1Δ* and double mutant spots. Student's *t* test was used to calculate significance. (A, D) Mean values and SEM are shown, *n = 3*.](mbc-30-191-g004){#F4}

Tubulin levels control genome integrity in splicing mutants
-----------------------------------------------------------

Only ∼5% of yeast genes are spliced, and the bulk of splicing flux is driven by ribosomal protein transcripts ([@B33]). Splicing of the *TUB1* transcript, encoding α-tubulin, has previously been implicated in cell-cycle delays in other splicing mutants ([@B7]; [@B14]). Moreover, mutant alleles of *TUB1* such as the cold-sensitive *tub1-1* have been shown to increase chromosome missegration at low temperatures ([@B24]) and lead to decreased Tub1 protein (Supplemental Figure S1E). Tub1 protein levels decreased in both *hsh155-1* and *snu114-60* mutants as temperature increased ([Figure 5A](#F5){ref-type="fig"}). RT-qPCR of *TUB1* mRNA under the same conditions indicated a mild decrease in *TUB1* mRNA expression in *hsh155-1* and *snu114-60*, which was accompanied by considerable intron retention ([Figure 5B](#F5){ref-type="fig"}), supporting the idea that defective *TUB1* mRNA splicing drives loss of protein. Indeed, we observed Tub1 protein-level decreases of variable penetrance in a panel of splicing factor mutants (i.e., alleles of *YHC1, SNU13, SYF1, CWC2, PRP4, PRP31*, and *PRP6)* (Supplemental Figure S1F), supporting that this is a general phenomenon. To directly connect defective *TUB1* splicing to genome maintenance, we retested CIN in *hsh155-1* and *snu114-60* encoding an intronless *TUB1* gene, *tub1*Δ*i*. As expected, *tub1*Δ*i* increased the amount of Tub1 protein expressed in each splicing mutant relative to WT ([Figure 5A](#F5){ref-type="fig"}). More importantly, intronless *TUB1* partially suppressed the CTF phenotype observed in *snu114-60* and *hsh155-1* ([Figure 5C](#F5){ref-type="fig"}). We also tested the effect of *tub1*Δ*i* on the rate of endogenous chromosome III missegregation using the LacO-LacI-GFP system and found suppression of aneuploidy in both splicing mutants ([Figure 5D](#F5){ref-type="fig"}). As expected, *tub1*Δ*i* has no effect on R-loop levels or recombination in *snu114-60*, demonstrating that there are multiple mechanisms, operating concurrently, that create genome instability in this strain (Supplemental Figures S1G and S1H). Importantly, the partial suppression of CIN phenotypes in both *hsh155-1* and *snu114-60* by *tub1Δi* support the idea that *TUB1*-independent mechanisms of genome instability must also be at play. We feel that it is likely that minor contributions from defects in multiple intron containing genes may combine with the effects of TUB1 dysregulation to promote the overall increase in genome instability seen in splicing mutants.

![Tubulin stability contributes to genome maintenance in splicing mutants. (A) Western blot of relative α-tubulin protein levels. Top, *TUB1*; bottom, intronless *TUB1*. (B) Quantification of *TUB1* mRNA transcript levels from exon region (left) and *TUB1* intron region (right) by RT-qPCR. Asterisks show *p* values of ΔΔCt: \*\*\**p* = 0.0002; \*\*\*\**p* \< 0.0001. (C) CTF phenotypes in *TUB1* or *tub1*Δ*i* strains. (D) Endogenous Chr III stability in *hsh155-1* and *snu114-60* with intronless *TUB1* (gray bars). (C, D) Fisher's exact test. (E) Model of defective splicing-induced genome instability in yeast. (B, C, D) Mean values with SEM are shown, *n = 3*.](mbc-30-191-g005){#F5}

Tubulin levels must be tightly regulated, and maintaining an equimolar ratio of α- to β-tubulin is known to be critical for functional spindles ([@B27]). Our data support a model ([Figure 5E](#F5){ref-type="fig"}) where intron retention and associated decreases in α-tubulin lead to sporadic chromosome missegregation, buffered by the SAC ([Figure 4](#F4){ref-type="fig"}). If this is true, then simple reduction of *TUB1* transcription should also cause genome instability even with normal splicing. To test this, we engineered strains where the *TUB1* gene was under the control of a galactose-regulated promoter in a WT or *tub1*Δ background. Shifting the strains to dextrose repressed Tub1 expression in the *tub1*Δ background (Supplemental Figure S1I) and led to a significant increase in CIN by the ALF assay (Supplemental Figure S1J). Thus, altered α-tubulin levels cause CIN, whether through splicing defects or decreased transcription.

Perspective
-----------

Determining sources of genome instability is important to understand the accumulation of mutations during cellular adaptation and in human disease. While much is known about DNA replication, repair, and mitosis, considerably less is known about the effects of other cellular pathways on the genome. Nonetheless, these noncanonical pathways account for a large proportion of reported genome maintenance factors ([@B39]). RNA processing has emerged as a major contributor to genome maintenance and various mechanisms have been described. Direct roles for some RNA processing factors have been found in DNA repair, such as the moonlighting function of Prp19 in ATR activation ([@B30]), or the role of the spliceosome in R-loop mediated ATM activation ([@B43]). More recently, dominant cancer-associated splicing mutations have been linked to RNA polymerase pausing and R-loop accumulation ([@B12]). Still other studies have suggested a role for the aberrant gene expression landscapes produced in RNA processing mutants as drivers of genome instability ([@B5]; [@B46]).

Overall, our data reveal how changes in information flux due to allele-specific effects on RNA maturation can influence specific mechanisms of genome instability. This is important as we have shown previously that \>150 yeast genes with functions in transcription, RNA processing and translation can be mutated to cause a genome instability phenotype ([@B39]). In principle, our data suggest that many of these mutants with broad impacts on gene expression could selectively impair a specific aspect of genome maintenance that can be identified. Indeed, cancer-associated mutations in core splicing factors like SF3B1, the orthologue of yeast Hsh155, are invariably nonsynonymous coding variants suggesting that subtle but specific changes in the transcriptome are required for cancer formation and maintenance ([@B15]). It will be important to employ sensitized genetic backgrounds and sensitive assays to enable direct study of cancer-associated SF3B1/Hsh155 alleles in yeast genome maintenance. Mechanistic studies of how specific mutations in the spliceosome alter the proteome in a specific cellular context could elucidate roles for spliceosomal mutations in cancer.

MATERIALS AND METHODS
=====================

Yeast strains, growth, and CIN assays
-------------------------------------

All yeast strains were in the s288c background (Supplemental Table S3) and were grown under standard conditions in the indicated media and growth temperature. To assess benomyl sensitivity, strains were compared between yeast extract peptone dextrose (YPD) + 0.2% dimethyl sulfoxide (DMSO) (control) or YPD + 15 μg/ml benomyl (Sigma-Aldrich cat. no.45339). Growth curves were conducted in YPD using a Tecan M200 plate reader and were compared using the area under the curve as previously described ([@B11]). Briefly, logarithmic phase cultures were diluted to OD 0.05 in a 96-well plate and grown for 24 h, with OD~600~ readings taken every 25 min. The chromosome transmission fidelity (CTF) and ALF assays were performed as described ([@B39]; [@B32]). In the ALF assay involving *tub1∆*, *tub1∆* mutant strain carrying a galactose-inducible *TUB1* plasmid was grown in either synthetic complete (SC) + 2% galactose or 2% dextrose media for 24 h, mixed with an excess of mating tester and plated onto synthetic defined (SD) media + 2% galactose or 2% dextrose at 30°C. The CTF assay measures inheritance of an artificial chromosome fragment as monitored by colony color to indicate chromosome instability--an induced *ade2-101* mutation pigments colonies red, and when supplemented with a chromosome fragment carrying suppressor mutation *SUP11*, the chromosome instability read-out was white (indicating no loss of fragment) or red (loss of fragment). The ALF assay measures the frequency of *MATα* locus loss in α-mating type haploid yeast, which indicates dedifferentiation to a-mating type haploid yeast. Cells that have lost this locus were detected by selection for mated diploid yeast. For plasmid loss, strains carrying *pRS313::HIS3* were grown overnight in SC-histidine and then plated on YPD and allowed to form colonies without selection before replica plating onto SC-histidine. The frequency of colonies that could not grow on SC-histidine is reported as the plasmid loss rate. For all experiments, significance of the differences was determined using Prism7 (GraphPad Software). For all experiments, sample means were compared with Fisher's exact test, Student's *t* tests or analysis of variance (ANOVA) for multiple comparisons as indicated.

Synthetic genetic array and validation
--------------------------------------

SGA screening was performed as described previously for *URA3*-marked query strains ([@B39]; [@B13]) and scored using the Balony software package ([@B50]). From raw colony scores, we chose a cutoff of *p* \< 0.05 and an experiment-control score of ≥\|0.5\| for list analysis and GO term enrichment using the Princeton generic GO term-finder (<http://go.princeton.edu/cgi-bin/GOTermFinder>) and visualized with REVIGO ([@B41]). *snu114-60* and *yhc1-1* interactions are available at <http://thecellmap.org> ([@B44]). For hit validation, fresh double mutant strains were made by tetrad dissection and tested in quantitative growth curves or by spot dilution assays. Observed area under the curve for double mutants was compared with a multiplicative model of the predicted fitness based on the fitness of the two single mutants.

Image and cell-cycle analysis
-----------------------------

Imaging of budding index by differential interference contrast (DIC) or fluorescence of Rad52-GFP and GFP labeled chromosome III was conducted on a Leica DMi8 microscope using an HCX plan apochromat 1.4 NA oil immersion 100× lens. The images were captured at room temperature by an ORCA Flash 4.0 V2 camera (Hamamatsu Photonics), using MetaMorph Premier acquisition software (Molecular Devices). Scoring was done in ImageJ (National Institutes of Health). For Rad52 foci, all cells were scored as negative or positive for a focus. Imaging of LacO-LacI-GFP labeled chromosome III was performed as described ([@B49]). For scoring, first unbudded cells were selected in the DIC channel and then scored for the presence of 1 or ≥2 LacI-GFP dots. Chromosome spreads were performed exactly as described; primary DNA-RNA Hybrid \[S9.6\] (Kerafast cat. no. ENH001); secondary Alexa Fluor 568 goat anti-mouse immunoglobulin G (Invitrogen cat. no. A-11004) ([@B47]).

Flow cytometry was done using the BD FACSCalibur platform. Cells were arrested in G1 by α-factor arrest using 10 µg/ml α-factor (Cedarlane, cat. no. Y1001) for 2.5 h, and samples were collected at 30, 90, and 150 min after wash-out. Cells were fixed with 70% ethanol and stained with 16 μg/ml propidium iodide (Sigma-Aldrich cat. no. 287075). The proportion of cells in G1, S, and G2/M cell cycles was quantified using FlowJo.

Splicing efficiency assay
-------------------------

Splicing assay protocol was performed as described ([@B19]). All measurements were taken with individual transformants in triplicate. Cells were struck as a patch on SC-leucine and then replica plated to glycerol-lactate--containing SC medium without leucine (GGL-leu). Cells from each patch were inoculated in liquid GGL-leu media for 2 h at 30°C and then were induced with final 2% galactose for 4 h. Cells carrying reporters were lysed and assayed for β-galactosidase assay using a Gal-Screen β-galactosidase reporter gene assay system for yeast or mammalian cells (Applied Biosystems) as per the manufacturer's instructions and read with a SpectraMax i3 (Molecular Devices). Relative light units were normalized to cell concentration as estimated by measuring OD~600~.

Recombination assays
--------------------

To construct the recombination plasmids, pRS314GLB ([@B17]) was linearized with *Bgl*II and ligated with *URA3* sequences with *Bgl*II sites ([@B2]). Following transformation and plasmid isolation, the presence of *URA3* was confirmed by Sanger sequencing. Direct repeat recombination assays were performed as described ([@B11]).

Western blot
------------

Whole-cell extracts were prepared by 100% trichloroacetic acid extraction (2 × 10^6^ cells). Lysates were separated on a 10% or 15% SDS--PAGE gel, transferred to nitrocellulose, and probed with the following antibodies: anti-Tub1 (Invitrogen cat. no. 32-2500) (1:500 dilution), anti-Pgk1 (Santa Cruz cat. no. sc-130335) (1:1000 dilution) as a loading control, Yra1 antibody (a gift from David Bentley, University of Colorado, Denver) (1:10,000 dilution), and Clb2 antibody (Santa Cruz Biotechnology cat. no. sc-6697, discontinued) (1:1000 dilution). ImageJ software was used to quantify protein bands ([@B37]).

RNA isolation, cDNA preparation, and reverse transcription--quantitative PCR analysis
-------------------------------------------------------------------------------------

Total RNA was isolated from 0.5--1 OD cell cultures shifted to 34°C for 3.5 h, using the yeast RiboPure RNA Purification kit (Ambion). cDNA (1 µg) was reverse transcribed using anchored-oligo(dT)18 primer and Transcriptor Reverse transcription (Roche). Reverse transcription--quantitative PCRs were performed and analyzed using SYBR green PCR Master Mix and a StepOnePlus Real-Time PCR system (Applied Biosystems). RQ values were normalized to an unspliced *SPT15* transcript and expressed relative to WT.
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